Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Breast Scanner Can Detect Early Signs of Cancer

05.12.2003


Researchers at Duke University Medical Center have developed a new breast scanner that is designed to detect subtle changes in breast cells before a lump can be felt by hand or seen with X-ray mammography.


Martin Tornai, Ph.D.



Such early detection should enable doctors to more successfully treat breast cancer before it has formed a tumor or spread to lymph nodes, said Martin Tornai, Ph.D., associate professor of radiology and biomedical engineering at Duke and developer of the device. The new camera has undergone extensive testing in artificial breasts and will begin testing in women this spring.

The camera uses nuclear medicine to pick up chemical changes to breast cells that signal the cells are becoming malignant, said Tornai. The camera should be particularly useful for detecting tumors in large or dense breasts, which are difficult to image using traditional mammography because X-rays often cannot penetrate them. Moreover, the geometry of the new device allows for imaging small breasts and the nearby chest wall. It can even image the axillary lymph nodes to look for evidence of metastasis -- which traditional mammography cannot do. The new device works without any breast compression, and women may not be required to remove their bras.


Tornai will present results with the new device Dec. 4, 2003, at the 26th Annual San Antonio Breast Cancer Symposium.

The key to the new scanner is that it detects changes in the behavior of cancer cells rather than structural changes, such as tumor masses, which take much longer to develop, said Tornai.

"Once you start seeing structural changes using mammography, that indicates the molecular process has been going on for awhile," he said. "If we can detect subtle changes in cells before a tumor has developed, we have a better chance of treating the abnormal cells in their earliest stages of malignancy."

To use the device, a cancer-specific radioactive tracer is injected into the patient’s bloodstream. The tracer, called sestamibi, is preferentially absorbed by cancer cells because they have large numbers of mitochondria, the cells’ powerhouses. Cancer cells have more mitochondria than normal cells because they are more metabolically active and require more energy to grow and spread.

Next, the camera obtains an image by picking up gamma rays -- high energy photons or units of light -- that are emitted by the radioactive atom attached to sestamibi. The gamma rays easily penetrate the tissue and can be detected non-invasively by a gamma ray camera.

"Nuclear imaging tracers like sestamibi show up in both pre-malignant and malignant breast cells as a little light bulb in the middle of a dim space," said Tornai. "You really want a tracer to home in on small bits of cancer that may otherwise be too small for other scanners to detect."

Gamma ray tracers such as sestamibi have a short half-life and are broken down quickly by the liver and excreted. The amount of radiation exposure from a single diagnostic procedure is about the same as a year’s exposure from the natural background radiation found in the environment, said Tornai, hence, they are relatively safe.

Early studies using existing clinical gamma cameras have been encouraging until now, said Tornai, but they have fallen short of being able to detect cancers smaller than a marble (one centimeter). The existing clinical nuclear medicine cameras are large whole-body scanners that take a single, two-dimensional image that cannot generally take multiple views of the breast. Furthermore, their cumbersome size makes it difficult to obtain a close image of the breast, which is critical to obtaining a complete, three-dimensional picture.

To overcome these limitations, Tornai developed a miniature gamma camera and rotating platform system that allows it to completely and closely orbit a breast, creating a high-resolution, three-dimensional image, called an emission or functional mammotomogram.

In early studies, Tornai and Duke colleagues Caryl Archer and James Bowsher, Ph.D., assistant research professor of radiology, optimized the imaging system using an artificial breast, which they implanted with small spheres that simulate cancerous growths. The spheres ranged from 4 millimeters, about the size of an early cancerous lesion, up to one centimeter. The researchers demonstrated that, in principle, it is possible to locate even a pinhead-sized lesion using the new device.

In clinical practice, the procedure would take 10 to 20 minutes per breast, and should be more comfortable for the patient than mammography, because the breast is not compressed during the procedure. Patients may not even need to remove their bra, since the device never touches the breast, noted Tornai.

As a screening device, functional mammotomography will not replace traditional mammography in most cases, said Tornai, but it could become a useful adjunct device in the mammography clinic.

"This technology could potentially be applied to screening women who are at high risk for breast cancer, particularly younger women who have denser breast tissue that X-ray mammography can’t easily penetrate," he said.

In addition, Tornai said the device could be useful to monitor the course of chemotherapy or radiation therapy in breast cancer patients because it could detect changes to the cancer cells.

"During and after chemotherapy, if you take an X-ray mammogram of the same cancerous tissue, it looks identical to its pre-treatment size," says Tornai. "But if you take a nuclear medicine image, the dead tissue doesn’t take up the tracer, so you can see if the therapy is having an effect very early on, much sooner than waiting for tumor shrinkage."

Tornai plans to begin imaging studies with patients at Duke in spring 2004, and will begin studies with physicians to determine how small a lesion can actually be detected with the naked eye from the resulting images.

The next step in the development of the device will be combining the nuclear medicine image with a dedicated X-ray computed tomography (CT) scan, which will provide a structural mammotomogram. This information can be overlayed with the functional information on the same three-dimensional image.

"One of the criticisms of nuclear medicine is that it is hard for physicians to read the grainy images," Tornai said. "For example, an X-ray will exquisitely show the bones in my hand, and as an analogy, a nuclear medicine image will show the ring on my finger which will appear to be floating in space. We need an imager that will show where the ring sits on my hand, and we can achieve that with a dual imager."

Tornai is awaiting patent approval on the new device, including the combination device that overlays X-ray and nuclear medicine images.

Becky Levine | dukemed news
Further information:
http://dukemednews.org/news/article.php?id=7257

More articles from Health and Medicine:

nachricht Why might reading make myopic?
18.07.2018 | Universitätsklinikum Tübingen

nachricht Unique brain 'fingerprint' can predict drug effectiveness
11.07.2018 | McGill University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First evidence on the source of extragalactic particles

For the first time ever, scientists have determined the cosmic origin of highest-energy neutrinos. A research group led by IceCube scientist Elisa Resconi, spokesperson of the Collaborative Research Center SFB1258 at the Technical University of Munich (TUM), provides an important piece of evidence that the particles detected by the IceCube neutrino telescope at the South Pole originate from a galaxy four billion light-years away from Earth.

To rule out other origins with certainty, the team led by neutrino physicist Elisa Resconi from the Technical University of Munich and multi-wavelength...

Im Focus: Magnetic vortices: Two independent magnetic skyrmion phases discovered in a single material

For the first time a team of researchers have discovered two different phases of magnetic skyrmions in a single material. Physicists of the Technical Universities of Munich and Dresden and the University of Cologne can now better study and understand the properties of these magnetic structures, which are important for both basic research and applications.

Whirlpools are an everyday experience in a bath tub: When the water is drained a circular vortex is formed. Typically, such whirls are rather stable. Similar...

Im Focus: Breaking the bond: To take part or not?

Physicists working with Roland Wester at the University of Innsbruck have investigated if and how chemical reactions can be influenced by targeted vibrational excitation of the reactants. They were able to demonstrate that excitation with a laser beam does not affect the efficiency of a chemical exchange reaction and that the excited molecular group acts only as a spectator in the reaction.

A frequently used reaction in organic chemistry is nucleophilic substitution. It plays, for example, an important role in in the synthesis of new chemical...

Im Focus: New 2D Spectroscopy Methods

Optical spectroscopy allows investigating the energy structure and dynamic properties of complex quantum systems. Researchers from the University of Würzburg present two new approaches of coherent two-dimensional spectroscopy.

"Put an excitation into the system and observe how it evolves." According to physicist Professor Tobias Brixner, this is the credo of optical spectroscopy....

Im Focus: Chemical reactions in the light of ultrashort X-ray pulses from free-electron lasers

Ultra-short, high-intensity X-ray flashes open the door to the foundations of chemical reactions. Free-electron lasers generate these kinds of pulses, but there is a catch: the pulses vary in duration and energy. An international research team has now presented a solution: Using a ring of 16 detectors and a circularly polarized laser beam, they can determine both factors with attosecond accuracy.

Free-electron lasers (FELs) generate extremely short and intense X-ray flashes. Researchers can use these flashes to resolve structures with diameters on the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Leading experts in Diabetes, Metabolism and Biomedical Engineering discuss Precision Medicine

13.07.2018 | Event News

Conference on Laser Polishing – LaP: Fine Tuning for Surfaces

12.07.2018 | Event News

11th European Wood-based Panel Symposium 2018: Meeting point for the wood-based materials industry

03.07.2018 | Event News

 
Latest News

Scientists uncover the role of a protein in production & survival of myelin-forming cells

19.07.2018 | Life Sciences

In the ocean's twilight zone, tiny organisms may have giant effect on Earth's carbon cycle

19.07.2018 | Earth Sciences

Lying in a foreign language is easier

19.07.2018 | Social Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>